[Editorial] Immunotherapy: hype and hope

As the dust settles after a busy week at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting (June 1–5, 2018; Chicago, IL, USA), there is an opportunity to reflect on the impact of the largest cancer congress of the year. The goal of "Delivering discoveries: expanding the reach of precision medicine" was evident throughout the event. Among this year's highlights were a predictive 21-gene expression assay that suggests most women with early-stage breast cancer might not need chemotherapy, and findings that pre-operative chemoradiotherapy improves disease-free survival for patients with pancreatic cancer.

https://ift.tt/2KlOMWL